Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
Globe Newswire•02/10/2026•08:00 ET
0
Key Highlights
- ➤$600 million seven-year Senior Secured Term Loan B launched by Integra LifeSciences (IART)
- ➤Net proceeds will refinance existing indebtedness and pay associated fees and expenses
- ➤Refinancing aims to extend maturities and maintain financial flexibility
- ➤Financing completion, size, terms, and pricing remain subject to market conditions
Expert Statements
Lea Knight, Executive Vice President and Chief Financial Officer of Integra LifeSciences
“This transaction allows us to refinance our existing debt, extend maturities and maintain financial flexibility. It positions us well as we continue to focus on disciplined capital allocation and deleveraging”
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of a proposed $600 million seven-year Senior Secured Term Loan B as part of a broader refinancing transaction.
The Company intends to use the net proceeds from the Term Loan B, together with other sources of financing, to refinance certain of its existing indebtedness and pay associated fees and expenses.
Get started
Create a free account to read the full story.